tiprankstipranks
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesVera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1M ago
Vera Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
PremiumPress Releases
Vera Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
1M ago
3 Best Stocks to Buy Now, 5/31/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 5/31/2024, According to Top Analysts 
2M ago
Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
PremiumPress ReleasesVera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
2M ago
Vera Therapeutics price target raised to $68 from $57 at Raymond James
PremiumThe Fly
Vera Therapeutics price target raised to $68 from $57 at Raymond James
2M ago
Vera Therapeutics expects cash to fund operations through U.S. atacicept launch
PremiumThe Fly
Vera Therapeutics expects cash to fund operations through U.S. atacicept launch
2M ago
Vera Therapeutics participates in a conference call with JPMorgan
PremiumThe FlyVera Therapeutics participates in a conference call with JPMorgan
3M ago
Novartis reports results from interim analysis of Phase 3 APPLAUSE-IgAN study
PremiumThe Fly
Novartis reports results from interim analysis of Phase 3 APPLAUSE-IgAN study
3M ago
Analyst thinks this drugmaker could be next after Alpine’s $4.9B acquisition
PremiumThe Fly
Analyst thinks this drugmaker could be next after Alpine’s $4.9B acquisition
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100